Article info
PDFNeuromuscular
Original research
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy
- Correspondence to Professor Eduardo Nobile-Orazio, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano 20122, Lombardia, Italy; eduardo.nobile{at}unimi.it
Citation
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy
Publication history
- Received April 24, 2020
- Revised August 1, 2020
- Accepted August 6, 2020
- First published August 31, 2020.
Online issue publication
September 15, 2020
Article Versions
- Previous version (31 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.